Live Stock Market Updates - Sensex, Nifty languish in red

Some buying activity is seen in realty, consumer durables, utilities, capital goods, pharma, banking, metal and FMCG sectors, while IT, energy, telecom, finance and oil & gas showing weakness on BSE. The BSE Mid-cap Index is trading up 0.06% at 11,327, whereas BSE Small-cap Index is trading up 0.56% at 11,375.


The BSE Sensex opened 85.73 points, or 0.32% up at 26482.50, while NSE Nifty opened 23.80 points, or 0.29% up at 8,134.40.

At 1:29 PM, the S&P BSE Sensex is trading at 26,328 down 69 points, while NSE Nifty is trading at 8,050 down 25 points.

India's annual wholesale price inflation (WPI) moved further higher into the positive zone at 0.79% against 0.34% in April and -2.20%  in the corresponding month of the previous year.

The BSE Mid-cap Index is trading up 0.06% at 11,327, whereas BSE Small-cap Index is trading up 0.56% at 11,375.

Adani Ports, Cipla, SBI, Tata Motors, ITC and GAIL are among the gainers, whereas HDFC, HUL, TCS, Hero MotoCorp, and Bajaj-Auto are losing sheen on BSE.

Some buying activity is seen in realty, consumer durables, utilities, capital goods, pharma, banking, metal and FMCG sectors, while IT, energy, telecom, finance and oil & gas showing weakness on BSE.

The INDIA VIX is up 4.49% at 17.3275. Out of 1,810 stocks traded on the NSE, 470 declined, 1,047 advanced and 293 remained unchanged today.

A total of 56 stocks registered a fresh 52-week high in trades today, while 15 stocks touched a new 52-week low on the NSE.

The Indian rupee depreciated against US Dollar in early trade. The rupee hit fresh 1-week low against US Dollar on sustained demand for the American currency from importers and bankers. Currently, the rupee trading at 67.16/$, down 3 paise.

Asian markets are trading on a mixed note. Nikkei 225 and Hang Seng in red. Shanghai Composite marginally up. Wall Street ended lower for a third straight session as Microsoft and Apple dragged on indexes.
On the economy front, CPI inflation increased to 21-months high of 5.76% in May 2016, while recording rise for second straight month. The CPI inflation had stood at 5.47% in April 2016. Investors also remained cautious ahead of WPI Inflation data for May which is scheduled to be released later in the day.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Deepak Fertilisers & Petrochemicals Corp Ltd jumped 6.5% to Rs.165 from its previous closing of Rs. 154.8 on the BSE. The company stated that Ministry of Chemicals and Fertilizers has agreed to release about Rs.485 crore outstanding subsidy payment to the company.

Unitech Ltd surged 9% to Rs.5.18 after the opening bell on the BSE. The apex consumer commission has asked the company to pay over Rs.48 lakh to a Delhi resident for failing to hand over an apartment in its Greater Noida project even after a decade, as per reports.

IVRCL Ltd has announced that pursuant to provisions of Companies Act, 2013 and SEBI (Issue of Capital Disclosure Requirement) Regulations, 2009 and implementation of SDR, the Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each, to Bank of Nova Scotia.

Jindal Steel and Power Ltd (JSPL) rose 1.2% to Rs.62.80 on the BSE. News reports stated that the company is set to get debt recast under the Reserve Bank's 5/25 scheme post deal with JSW Energy.

Jivox raises $6 million in new financing

“We view this strategic investment by one of today's frontrunners in digital marketing as strong testament to the strength of Jivox's Bangalore-based R&D team -- and clear evidence of their success in developing the world's most state-of-the art platform for personalized digital advertising”, said Naren Nachiappan, Co founder & Managing Director India of Jivox.

San Mateo California based digital marketing platform leader Jivox, having its R&D centre in Bengaluru, announced it has raised $6 million in new financing, led by the world's first “Brandtech” group You & Mr Jones and its founder David Jones, the former global CEO of advertising conglomerate Havas. You & Mr Jones will also join Jivox’s board of directors, and its senior management team will play a hands-on role in guiding the company into the next phase of its growth.

“We view this strategic investment by one of today's frontrunners in digital marketing as strong testament to the strength of Jivox's Bangalore-based R&D team -- and clear evidence of their success in developing the world's most state-of-the art platform for personalized digital advertising”, said Naren Nachiappan, Co founder & Managing Director India of Jivox."The Jivox IQ platform features the very best innovations in Big Data architectures and machine-learning algorithms, and delivers industry-leading analytics and optimization capabilities. Backed by significant new capital and strategic guidance from our expanded board, we expect to double the strength of our development team in the short term, underpinning our ability to drive even greater innovations in the future.”

“David Jones is at the vanguard of a completely new paradigm in marketing–bringing both brand expertise and a carefully curated ecosystem of the most advanced marketing technologies,” said Diaz Nesamoney, founder and CEO of Jivox. “As the only platform for personalized digital marketing within the You & Mr Jones portfolio, we’re pleased by the endorsement this confers on Jivox’s technology and our team.

“As brand marketers continue seeking ways to improve the performance of their marketing, the demand for data-driven, highly personalized marketing campaigns has skyrocketed–driving significant interest in platforms that can bring scale and automation to an otherwise complex, manual and error-prone process.”

Founded in 2007, Jivox enables some of the world's most successful brands and media companies to deliver sophisticated, highly personalized digital marketing and advertising campaigns. This new data-driven approach to digital marketing is completely transforming the way companies communicate with people.

David Jones, founder and CEO of You & Mr Jones said: “We’re extremely interested in the whole area of machine-generated creativity. We don’t believe people hate brands or branded content – they just don’t want to hear from brands they are not interested in with irrelevant messaging, hence why ad blockers are becoming so prevalent. Jivox solves this issue for brands by combining data and technology to deliver tens of thousands of different versions of highly personalized, relevant ads that are based upon what people are actually interested in.

“We think the programmatic creative space has a huge future. Jivox is a very exciting company, both in terms of what its technology offers and its proven ability to deliver for brands. Diaz’s track record speaks for itself and the Jivox platform is a great addition to our Brandtech ecosystem.”

Jivox’s impressive growth lies at the heart of a key need identified in a recent report from Accenture– The Future of Digital Advertising:“Companies not wired to be thinking about personalization will really struggle going forward. Re-targeting is not the answer; consumers move on too quickly. They want the right message, at the right time, on the right device, right now.”

Jivox brought to market the first and only platform built from the ground up to manage the complexities of personalized digital marketing. Utilizing a robust content management system, technology for dynamically assembling creative in real time and advanced machine- learning algorithms to analyze and optimize campaigns, Jivox has been credited with reinventing the market for personalized dynamic creative.

The move to programmatic media buying has significantly reduced performance and engagement by users leading them to resort to ad blocking and other means to avoid being interrupted by thousands of irrelevant ads each day. Personalized marketing technology ensures the right creative experience is delivered to the right person at the right time.

In addition to You & Mr Jones, existing investors Fortisure Ventures and Jivox CEO Diaz Nesamoney participated in the current financing round. Jivox will invest its new capital in growing sales and marketing globally as well as continuing to invest in its market-leading platform.

SKS Microfinance renamed Bharat Financial Inclusion

SKS Microfinance Ltd has announced that pursuant to the approval of the Government of India - Ministry of Corporate Affairs, Registrar of Companies, Maharashtra, Mumbai ("GOI"), the name of the Company has been changed from 'SKS Microfinance Limited' to 'Bharat Financial Inclusion Limited' w.e.f. June 13, 2016.

SKS Microfinance has announced that pursuant to the approval of the Government of India - Ministry of Corporate Affairs, Registrar of Companies, Maharashtra, the name of the company has been changed from 'SKS Microfinance Limited' to 'Bharat Financial Inclusion Limited' w.e.f. June 13, 2016.

Stock commentary:

SKS Microfinance Ltd is currently trading at Rs. 670.2, up by Rs. 1.75 or 0.2% from its previous closing of Rs. 668.4 on the BSE.

The scrip opened at Rs. 666 and has touched a high and low of Rs. 674.4 and Rs. 666 respectively. The current market cap of the company is Rs. 8514.6 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 695.6 on 09-Jun-2016 and a 52 week low of Rs. 369.4 on 18-Sep-2015. Last one week high and low of the scrip stood at Rs. 695.6 and Rs. 664.5 respectively.

The promoters holding in the company stood at 2.6% while Institutions and Non-Institutions held 77% and 20.2% respectively.

The stock is currently trading above its 50 DMA.

Ajanta Pharma launches Memantine Hydrochloride tablets in US

The company has launched it in 2 strengths 5mg & 10 mg tablets to address different levels of treatment.

Ajanta Pharma announced the launch of Memantine Hydrochloride Tablets in the US market. The company has launched it in 2 strengths 5mg & 10 mg tablets to address different levels of treatment.

Ajanta Pharma Ltd is currently trading at Rs. 1588, up by Rs. 26.7 or 1.7% from its previous closing of Rs. 1561.2 on the BSE.

The scrip opened at Rs. 1568.2 and has touched a high and low of Rs. 1593 and Rs. 1560 respectively. The current market cap of the company is Rs. 13739.7 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720 on 12-Aug-2015 and a 52 week low of Rs. 1103 on 18-Jan-2016. Last one week high and low of the scrip stood at Rs. 1589.7 and Rs. 1531.2 respectively.

The promoters holding in the company stood at 73.78 % while Institutions and Non-Institutions held 11.67 % and 14.55 % respectively.

The stock is currently trading above its 50 DMA.

Block deal on Reliance Infra; stock up 1.5%

Around 26.6 lakh shares were traded in a single block at Rs. 541.50 on the BSE.

Reliance Infrastructure rose 1.5% to Rs. 544 on Tuesday. Around 26.6 lakh shares were traded in a single block at Rs. 541.50 on the BSE.

The scrip opened at Rs. 538 and has touched a high and low of Rs. 548.6 and Rs. 538 respectively. The current market cap of the company is Rs. 14100.2 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 622 on 05-Jan-2016 and a 52 week low of Rs. 282.2 on 25-Aug-2015. Last one week high and low of the scrip stood at Rs. 559.4 and Rs. 524.5 respectively.

The promoters holding in the company stood at 48.3% while Institutions and Non-Institutions held 36.1% and 12.5% respectively.

Drugmakers get NPPA notice for pricing violation and other top pharma news

It is one company in the troubled largecap pharmaceuticals space, which has neither created shareholder wealth nor performed on fundamentals in the last one year.

Concerned over ‘wilful violation’ of its drug pricing control rules, the National Pharmaceutical Pricing Authority (NPPA) has slapped showcause notices on ten top drugmakers for failing to register their products on its online database and submit the mandatory disclosures. The authority, which plans to issue notices to more firms that have not furnished the information so far, warned that it would have to launch prosecution, among other legal actions, under the Essential Commodities Act. 

It is one company in the troubled largecap pharmaceuticals space, which has neither created shareholder wealth nor performed on fundamentals in the last one year. Sun Pharma is seen to be swallowing a pill far more bitter than most of its four large-cap peers — Aurobindo Pharma, Cipla, Dr Reddy’s and Lupin. This is has been revealed in an FC Research Bureau analysis of share price movement over the last one year and the fundamentals performance in financial year 2015-16 (FY16), based on data from Capitaline database. 

Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December. It said that even if the US Food and Drug Administration decides to hold back appro val s from the Goa facility it won't have much impact on the company as majority of pending approvals are from its other manufacturing sites. “We have actually committed till December to the FDA, but we are trying internally to actually make it happen even sooner,” Lupin M D Nilesh Gupta said. 

Granules announced an in-licensing deal with US pharma Windlas for four abbreviated new drug applications (ANDAs) awaiting approval in the US. Granules will make milestone payments and commit share of the profits from commercial sales to US pharma Windlas. Granules expects to be a co-first-to-file (FTF) for each of products, though eventually we expect intense generic competition once other Para IV’s launch after the exclusivity period. 

Dr Reddy’s Laboratories Ltd, India’s second largest drug maker, said it plans to commercialise by 2017-18 at least four of the eight generic drugs it acquired from Israel-based Teva Pharmaceutical Industries Ltd.  Of the eight products the Indian drug maker acquired from Teva for $350 million, one has been approved by the US Food and Drug Administration (FDA) and the rest are awaiting the agency’s green light. In an email reply to questions from Mint, Hyderabad-based Dr Reddy’s said on Monday that the portfolio of acquired drugs comprised complex generic products across dosage forms and therapeutic areas with annual sales of around $3.5 billion. 

Teva Pharmaceutical says it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied. The company says anyone who has a patch should not use it. Zecuity is a disposable battery-powered patch that is applied to the upper arm or thigh to ease migraine headaches. 

IVRCL allots 6.4 lakh shares to Bank of Nova Scotia; surges 5%

The Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each to Bank of Nova Scotia.

IVRCL Ltd has announced that pursuant to provisions of Companies Act, 2013 and SEBI (Issue of Capital Disclosure Requirement) Regulations, 2009 and implementation of SDR, the Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each, to Bank of Nova Scotia.

IVRCL Ltd is currently trading at Rs. 5, up 5.2% from its previous closing of Rs. 4.8 on the BSE.

The scrip opened at Rs. 4.9 and has touched a high and low of Rs. 5.1 and Rs. 4.9 respectively. The current market cap of the company is Rs. 377.8 crore.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 12.8 on 07-Aug-2015 and a 52 week low of Rs. 3.7 on 27-May-2016. Last one week high and low of the scrip stood at Rs. 4.9 and Rs. 3.8 respectively.

The promoters holding in the company stood at 5.7% while Institutions and Non-Institutions held 53.4% and 40.7% respectively.

The stock is currently trading above its 200 DMA.

Reliance Defence rises 2%

The company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

The scrip opened at Rs. 61.9 and has touched a high and low of Rs. 63.8 and Rs. 61.8 respectively. So far 371585(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 4516.65 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 114 on 28-Dec-2015 and a 52 week low of Rs. 51.45 on 25-Aug-2015. Last one week high and low of the scrip stood at Rs. 67.75 and Rs. 58.7 respectively.

The promoters holding in the company stood at 29.9 % while Institutions and Non-Institutions held 14.22 % and 55.88 % respectively.

The stock is currently trading below its 200 DMA.

L&T plans to list L&T Infotech by October

The company had received capital markets regulator Sebi’s approval to float initial public offering worth Rs 2,000 crore in December 2015.

Larsen & Toubro is planning to list its IT arm L&T Infotech by October this year, according to reports.

Report says that the company expects to raise between Rs 2,000-2,600 crore from the initial public offer.

The company had received capital markets regulator Sebi’s approval to float initial public offering worth Rs 2,000 crore in December 2015.

Top 19 stocks in focus: Bharti Infratel, Coal India, IVRCL

Check out the companies which will be in focus during trade today based on recent and latest news developments.

Bharti Infratel: Kotak Mahindra Capital Company Ltd ("Manager to the Buyback Offer") has submitted to BSE a Copy of Public Announcement ("PA") in respect of the Buyback of 47,058,823 equity shares of INR 10/- each (“Share”) of Bharti Infratel Ltd (“Company”) at a price of INR 425/- per Share under tender offer route (“Buyback”).

Coal India Ltd: Coal India has announced that the Board of Directors of Western Coalfields Limited ("WCL"), the Company's subsidiary, has considered and approved the buyback of 7,42,750 fully paid equity shares of face value of Rs.1,000 each.

JSPL: Jindal Steel and Power Limited is set to get debt recast under the Reserve Bank's 5/25 scheme post deal with JSW Energy, as per media report.

IVRCL: The company has allotted 6.46 lakh equity shares at a price of Rs.8.76 each to Bank of Nova Scotia. The company has informed BSE that the allotment is according to the Strategic Debt Restructure terms the company has with its lenders.

Satin Creditcare: Satin Creditcare Network Ltd has informed BSE about intimation regarding allotment of preference shares of 2.5 crore with a face value of Rs 10 each.

Larsen & Toubro: The company is planning to list its IT arm L&T Infotech by October this year, according to reports.

Rajesh Exports: The company has announced that its Board approved acquisition in the Middle East.

Man Industries (India) Ltd: The company has announced that the Company is one of the major Global player with lowest Project cost in Line Pipe Industry has achieved another land mark by successfully commissioning of state of the art 5600 Ton Hydraulic JCO press at its Gujarat Plant which has been developed indigenously with in-house research, development and technical knowhow.

Oriental Bank of Commerce: The Bank intends to raise Tier II Capital through Private Placement of Basel III Compliant Tier II Bonds of Rs. 10,00,000/- each at par aggregating to Rs. 500 crore with an option to retain oversubscription of upto Rs. 500 crore.

Deepak Fertilisers & Petrochemicals Corporation Ltd: The company announced that Department of Fertilizers (DoF), Ministry of Chemicals and Fertilizers, has been withholding subsidy claims due to the Company in accordance with applicable Nutrient Based Subsidy [NBS] Scheme of the Government of India, since June, 2014 amounting to Rs. 795 crores as on March 31, 2016.

Havells India Ltd: The Company is launching solar solutions including Solar power generating systems, Home lighting kits, Solar Pumps, Solar street lights etc. The products will be assembled/ manufactured in Neemrana and will be rolled out pan India in phases starting from June 2016, catering to the domestic market.

ABB: The company has successfully commissioned five substations to integrate a 648-megawatt (MW) solar project at Kamuthi in the southern Indian state of Tamil Nadu to the national transmission grid.

Omaxe Ltd: The company sold residential and commercial properties worth Rs 1,648 crore in last fiscal, up 11 per cent from the 2014-15, says report.

Banking stocks in focus: Reserve Bank of India released a paper on stressed assets called Scheme for Sustainable Structuring of Stressed Assets.

KPIT Technologies: KPIT will be in focus as it informed BSE that it intends to vigorously defend against Copart's alleged claims, and pursue any available claims against Copart. Sparta Consulting Inc, a 100% subsidiary of KPIT Technologies, was hired by Copart Inc (Copart), a US corporation, to design a replacement for its legacy Enterprise Resource Planning system.

DLF: Blackstone Group, GIC of Singapore and Brookfield Asset Management have fired slightly over $1 bn separate bids to acquire a 40% stake in DLF's commercial property unit that owns rent-yielding assets,as per media report.

Jubilant FoodWorks: Jubilant FoodWorks is planning to open 130-140 new Domino's Pizza outlets and around 20 new Dunkin' Donuts restaurants in the current fiscal to expand its footprints in the country.

Delta Corp: Delta Corp has now informed BSE that Delta Pleasure Cruise Company Private Limited, a wholly owned subsidiary of Delta Corp Limited, has been granted license by the Government of Goa to operate their vessel "M V ROYALE FLOTEL -DELTIN CARAVELA" in the Mandovi River.

TCS: Tata Consultancy Services (TCS) announced a global partnership with Randstad Global IT Solutions, to design and deploy one of the world’s largest end-to- end public cloud marketplaces for IT infrastructure services.